Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

354 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Drug Survival of Biologics in Patients With Hidradenitis Suppurativa.
Ring HC, Maul JT, Yao Y, Wu JJ, Thyssen JP, Thomsen SF, Egeberg A. Ring HC, et al. Among authors: egeberg a. JAMA Dermatol. 2022 Feb 1;158(2):184-188. doi: 10.1001/jamadermatol.2021.4805. JAMA Dermatol. 2022. PMID: 34851360 Free PMC article.
Amplicon sequencing demonstrates comparable follicular mycobiomes in patients with hidradenitis suppurativa compared with healthy controls.
Ring HC, Thorsen J, Fuursted K, Bjarnsholt T, Bay L, Egeberg A, Ingham AC, Vedel Nielsen H, Frew JW, Saunte DML, Thomsen SF, Jemec GB. Ring HC, et al. Among authors: egeberg a. J Eur Acad Dermatol Venereol. 2022 Jul;36(7):e580-e583. doi: 10.1111/jdv.18075. Epub 2022 Mar 22. J Eur Acad Dermatol Venereol. 2022. PMID: 35285081 No abstract available.
Drug Survival of Adalimumab, Secukinumab, and Ustekinumab in Psoriasis as Determined by Either Dose Escalation or Drug Discontinuation during the First 3 Years of Treatment - a Nationwide Cohort Study.
Thein D, Rosenø NAL, Maul JT, Wu JJ, Skov L, Bryld LE, Rasmussen MK, Ajgeiy KK, Thomsen SF, Thyssen JP, Egeberg A. Thein D, et al. Among authors: egeberg a. J Invest Dermatol. 2023 Nov;143(11):2211-2218.e4. doi: 10.1016/j.jid.2023.04.009. Epub 2023 Apr 27. J Invest Dermatol. 2023. PMID: 37119965 Free article.
Long-term drug survival of adalimumab, infliximab, secukinumab and ustekinumab in hidradenitis suppurativa: a Danish nationwide cohort study.
Ring HC, Thorsen J, Kirby B, Ingram JR, Rosenø NAL, Holgersen N, Nielsen VW, Thein Aagaard DN, Maul JT, Wu JJ, Thyssen JP, Egeberg A, Thomsen SF. Ring HC, et al. Among authors: egeberg a. Br J Dermatol. 2024 Apr 17;190(5):769-771. doi: 10.1093/bjd/ljae042. Br J Dermatol. 2024. PMID: 38305415 No abstract available.
354 results